- Home
- AUTL vs FRA Comparison
AUTL vs FRA Comparison
Compare AUTL & FRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- FRA
- Stock Information
- Founded
- AUTL 2014
- FRA 2003
- Country
- AUTL United Kingdom
- FRA United States
- Employees
- AUTL N/A
- FRA N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- FRA Investment Bankers/Brokers/Service
- Sector
- AUTL Health Care
- FRA Finance
- Exchange
- AUTL Nasdaq
- FRA Nasdaq
- Market Cap
- AUTL 415.2M
- FRA 464.9M
- IPO Year
- AUTL 2018
- FRA N/A
- Fundamental
- Price
- AUTL $1.76
- FRA N/A
- Analyst Decision
- AUTL Strong Buy
- FRA
- Analyst Count
- AUTL 5
- FRA 0
- Target Price
- AUTL $9.12
- FRA N/A
- AVG Volume (30 Days)
- AUTL 4.8M
- FRA 165.4K
- Earning Date
- AUTL 11-11-2025
- FRA 01-01-0001
- Dividend Yield
- AUTL N/A
- FRA 11.06%
- EPS Growth
- AUTL N/A
- FRA N/A
- EPS
- AUTL N/A
- FRA N/A
- Revenue
- AUTL $29,934,000.00
- FRA N/A
- Revenue This Year
- AUTL $641.63
- FRA N/A
- Revenue Next Year
- AUTL $109.21
- FRA N/A
- P/E Ratio
- AUTL N/A
- FRA N/A
- Revenue Growth
- AUTL 185.17
- FRA N/A
- 52 Week Low
- AUTL $1.11
- FRA $11.33
- 52 Week High
- AUTL $5.00
- FRA $13.10
- Technical
- Relative Strength Index (RSI)
- AUTL 48.20
- FRA 44.47
- Support Level
- AUTL $1.45
- FRA $12.61
- Resistance Level
- AUTL $1.65
- FRA $13.01
- Average True Range (ATR)
- AUTL 0.10
- FRA 0.10
- MACD
- AUTL 0.03
- FRA -0.01
- Stochastic Oscillator
- AUTL 56.09
- FRA 66.07
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About FRA Blackrock Floating Rate Income Strategies Fund Inc
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.